Search
Clinician Ordering Portal
Resources
Helpful references to learn more about DecisionDx-SCC
Hear from experts and patients alike and learn more about improving risk assessment in DecisionDx-SCC patients.
Expert opinions on the treatment and management of squamous cell carcinoma.
-
Brent Moody, MD, FACP, FAAD, Dermatologist and Mohs Surgeon, Heritage Medical Associates
Learn how Mohs Surgeon Dr. Brent Moody utilizes DecisionDx-SCC for his high-risk SCC patients to clarify their cancer management and treatment plans.
-
David Cotter, MD, PhD, Dermatologist, Las Vegas Dermatology
Learn about what Dermatologist Dr. David Cotter finds most valuable about utilizing DecisionDx-SCC to personalize care for his high-risk SCC patients.
-
Philip Andrews, NP, Dermatology, Chattanooga Skin and Cancer Clinic
Learn how Dermatology Nurse Practioner Philip Andrews utilizes DecisionDx-SCC to improve follow-up, referral and treatment recommendations for his high-risk SCC patients.
Explore on-demand content
-
AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients
Jason Newman, MD, FACS, Professor of Otorhinolaryngology – Head and Neck Surgery, University of Pennsylvania
CME/CE: N/A
-
Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.
Faculty: Brent Moody, MD, FACP, FAAD, Fellow, American College of Mohs Surgery
CME/CE: N/A
-
Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study
Sherrif F. Ibrahim, MD, PhD, Assistant Professor, Department of Dermatology, University of Rochester Medical Center
CME/CE: N/A
-
The DecisionDx-SCC test is a game changer”
Phil Andrews, NP/PA